Series D - Gemin X Pharmaceuticals - Apr 20, 2010 Funding Round Profile - Cointime

Bitcoin $92,891.78 -3.22%
Ethereum $3,313.19 +0.04%
BNB $681.51 +3.86%
Optimism $1.79 +0.66%
Arbitrum $0.76 +1.15%
Solana $185.24 +1.90%
Polygon $0.47 -1.57%
Cosmos $6.51 +0.04%
Avalanche $36.70 -1.14%

Bitcoin $92,891.78 -3.22%
Ethereum $3,313.19 +0.04%
BNB $681.51 +3.86%
Optimism $1.79 +0.66%
Arbitrum $0.76 +1.15%
Solana $185.24 +1.90%
Polygon $0.47 -1.57%
Cosmos $6.51 +0.04%
Avalanche $36.70 -1.14%

Gemin X Pharmaceuticals

company

Funding Round

Series D

Money Raised

$ 16M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Caxton Advantage Life Sciences Fund	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 3, 2008	Series C	$ 38M	Canadian Medical Discoveries Fund,Caxton Advantage Life Sciences Fund,etc.	Detail